Vimarsana
Biggest News Aggregation in the World

Florian Rieder News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Florian Rieder. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Florian Rieder Today - Breaking & Trending Today

Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders - Vimarsana News

Palisade Bio Announces Formation of Clinical Advisory Board with Appointments of Preeminent Key Opinion Leaders

Bruce Sands, MD, MS.,Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenter...

Palisade Bio Announces Formation of Clinical Advisory Board - Vimarsana News

Palisade Bio Announces Formation of Clinical Advisory Board

Bruce Sands, MD, MS., Dr. Burrill B. Crohn Professor of Medicine, Icahn School of Medicine at Mount Sinai and System Chief, Division of Gastroenterology,...

Correction Notice of Palisade Bio's Press Release - Vimarsana News

Correction Notice of Palisade Bio's Press Release

Carlsbad, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc.  (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company...

$4.9 million grant awarded to build EndO-trial consortium for improving the lives of Crohn's patients - Vimarsana News

$4.9 million grant awarded to build EndO-trial consortium for improving the lives of Crohn's patients

Cleveland Clinic and the University of Western Ontario have been awarded a $4.9 million grant from Helmsley Charitable Trust to build a consortium to develop clinical trial outcome tools for patients with Crohn's disease and permanent ileostomy.

Helmsley Charitable Trust awards $5.3 million to Cleveland Clinic, Mayo Clinic and Alimentiv for Crohn's disease research - Vimarsana News

Helmsley Charitable Trust awards $5.3 million to Cleveland Clinic, Mayo Clinic and Alimentiv for Crohn's disease research

The Leona M. and Harry B. Helmsley Charitable Trust awarded the funds to expand its support of the Stenosis Therapy and Anti-Fibrotic Research (STAR) consortium for the development of biomarker tools for intestinal fibrosis in patients with Crohn's disease.